30
Egyptian Holding Company for Pharmaceuticals (HoldiPharma) says it targets an 11.5 percent increase in net profit to reach 145 million Egyptian pounds ($8 million) within the financial year 2017/2018.
The company also plans to boost revenues by 7.5 percent to register 260 million pounds within the financial year 2017/2018.
Mohamed Wanees, HoldiPharma’s chairman, said that the affiliates seek to increase its activity revenues by 47.8 percent to around 16 billion pounds within the next financial year.
